Caribou Biosciences Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Caribou Biosciences, Inc. (CRBU) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-149.11-102.07-99.42-66.92-34.31
Depreciation & Amortization3.933.531.621.040.90
Stock Based Compensation16.7113.7511.723.451.00
Change in Working Capital-5.11-6.68-4.2027.890.18
Change in Accounts Receivable0.610.880.19-1.16-0.64
Change in Accounts Payable-0.351.82-2.721.140.04
Change in Other Working Capital-5.373.283.26-0.871.87
Other Operating Activities-4.6111.96-0.626.05-4.92
Net Cash from Operating Activities-138.20-93.29-90.97-32.52-33.22
Investing Activities
Capital Expenditures-6.51-11.61-6.452.12-0.32
Acquisitions0.000.00-0.60-1.000.00
Purchases of Investments-304.39-394.76-86.20-173.287.67
Sales/Maturities of Investments397.49338.19-0.60-173.28-1.00
Other Investing Activities-1.610.000.000.000.00
Net Cash from Investing Activities86.61-68.18-93.25-176.406.36
Financing Activities
Debt Repayment0.000.000.00-1.700.00
Common Stock Issued15.19152.722.13321.020.27
Other Financing Activities1.530.002.733.550.00
Net Cash from Financing Activities16.72154.302.13433.431.74
Summary
Net Change in Cash-34.87-7.18-182.08224.51-25.12
Cash at Beginning of Period51.2158.38240.4715.950.00
Cash at End of Period16.34244.9058.38240.470.00
Free Cash Flow-144.71-93.29-97.42-34.64-33.53
Supplemental Disclosures
Income Taxes Paid0.000.170.000.010.02